Ipsos SA (IPS):企業の財務・戦略的SWOT分析

◆英語タイトル:Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8967
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ipsos SA (IPS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ipsos SA (Ipsos) is a survey-based marketing research firm that delivers information of markets and people, brands, and society. Its service offerings helps clients in understanding markets, brand strategy, innovation and forecasting, product and package testing, purchase path and shopper research, and healthcare solutions. It also helps companies to measure and improve business and marketing performance through insights, integrated analytics, and expert advice. The company collects, processes, and delivers quantitative survey data in offline and online channels. It collects data through face-to-face, omnibus surveys, and telephone interview modes. The company interprets, simulates, and anticipates the needs and reactions of consumers, customers and citizens across Europe, the Middle East, Africa, Americas, and Asia-Pacific. Ipsos is headquartered in Paris, France.

Ipsos SA Key Recent Developments

Aug 20,2018: Ipsos appoints CEO for South East Asia
Jul 25,2018: Ipsos reports first-half 2018 results
Jul 03,2018: Katharine Zhou Appointed Managing Director for Ipsos in Singapore
May 08,2018: Carin Hercock appointed as Managing Director Ipsos

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Ipsos SA – Key Facts 6
Ipsos SA – Key Employees 7
Ipsos SA – Major Products and Services 9
Ipsos SA – History 10
Ipsos SA – Company Statement 12
Ipsos SA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 16
Company Overview 16
Ipsos SA – Business Description 17
Business Segment: Client and Employee Relationship Management 17
Overview 17
Performance 17
Business Segment: Marketing Research 17
Overview 17
Performance 17
Business Segment: Media and Advertising Research 17
Overview 17
Performance 17
Business Segment: Opinion & Social Research 17
Overview 17
Performance 18
Geographical Segment: Americas 18
Target Markets 18
Performance 18
Geographical Segment: Asia-Pacific 18
Target Markets 18
Performance 18
Geographical Segment: Europe, Middle East and Africa 18
Target Markets 18
Performance 18
Ipsos SA – Corporate Strategy 19
Ipsos SA – SWOT Analysis 20
SWOT Analysis – Overview 20
Ipsos SA – Strengths 20
Ipsos SA – Weaknesses 21
Ipsos SA – Opportunities 22
Ipsos SA – Threats 23
Ipsos SA – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Recent Developments 32
Jul 25, 2018: Ipsos reports first-half 2018 results 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Ipsos SA, Key Facts 6
Ipsos SA, Key Employees 7
Ipsos SA, Major Products and Services 9
Ipsos SA, History 10
Ipsos SA, Other Locations 13
Ipsos SA, Subsidiaries 13
Ipsos SA, Key Competitors 24
Ipsos SA, Ratios based on current share price 25
Ipsos SA, Annual Ratios 26
Ipsos SA, Annual Ratios (Cont...1) 27
Ipsos SA, Annual Ratios (Cont...2) 28
Ipsos SA, Interim Ratios 30
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Ipsos SA, Performance Chart (2013 - 2017) 29
Ipsos SA, Ratio Charts 31

★海外企業調査レポート[Ipsos SA (IPS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fiskars Corporation:企業の戦略・SWOT・財務情報
    Fiskars Corporation - Strategy, SWOT and Corporate Finance Report Summary Fiskars Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Vanguard Natural Resources, LLC (VNRSQ)-石油・ガス分野:企業M&A・提携分析
    Summary Vanguard Natural Resources, LLC (Vanguard) is an upstream company. It acquires, produces, and develops oil and natural gas properties. The company owns Green River Basin, Permian Basin, Piceance Basin, Gulf Coast Basin, Arkoma Basin, Big Horn Basin, Williston Basin, Anadarko Basin, and Wind …
  • Range Resources Corp (RRC)-石油・ガス分野:企業M&A・提携分析
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • Dakota Gasification Co:企業の戦略的SWOT分析
    Dakota Gasification Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BioDot Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioDot Inc (BioDot) is a non-contact and quantitative fluid dispensing system manufacturer. The company’s application comprises rapid test, cytogenetics and life science. It provides lateral flow, immunoblots, dry chemistry, low volume PCR, bio chips, biosensors, fish, karyotyping and LIS in …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Indian Oil Corporation Limited:企業の戦略・SWOT・財務情報
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • Den-Mat Holdings LLC-医療機器分野:企業M&A・提携分析
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that develops and manufactures dental products. The company provides products such as curing lights, finishing and polishing, impressions, instruments, lesion detection, magnification/illumination, oral hygiene, restoratives, soft ti …
  • Adris grupa d.d.:企業の戦略・SWOT・財務情報
    Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report Summary Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • Karambunai Corporation Berhad:企業の戦略・SWOT・財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • 3W Power SA:企業の戦略的SWOT分析
    3W Power SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • XALT Energy LLC:企業の戦略的SWOT分析
    XALT Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • 21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • Micronics Inc:企業の製品パイプライン分析2018
    Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products. The company provides products that include aborhcard and pannat system. Its research and development products comprise single-use, stand alone, disposable microfluidics-enabled cartr …
  • GENEWIZ Inc:医療機器:M&Aディール及び事業提携情報
    Summary GENEWIZ Inc (GENEWIZ) is a provider of genomics and technical support services. The company’s services comprise next generation sequencing, sanger sequencing, gene synthesis, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, oligo synthesis services and GLP-compliant serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆